Substance use in young persons in Ireland, a systematic review

被引:10
作者
Murphy, Kevin [1 ,2 ]
Sahm, Laura [1 ]
McCarthy, Suzanne [1 ]
Lambert, Sharon [2 ]
Byrne, Stephen [1 ]
机构
[1] Natl Univ Ireland Univ Coll Cork, Sch Pharm, Cork, Ireland
[2] Matt Talbot Serv, Cork, Ireland
关键词
Tobacco; Alcohol; Cannabis; Benzodiazepines; Adolescent; Ireland; AGE; INDEX; ONSET; DRINKING; SMOKING;
D O I
10.1016/j.addbeh.2013.03.016
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Adolescence is a time of physical and mental development when small changes can impact on the rest of a person's life. Substance use in this crucial period can have long-lasting consequences for the individual and for society. The prevalence of substance use in young people is an area of concern for policy makers and health workers. This systematic review looked at prevalence for four substances: alcohol, tobacco, cannabis, and benzodiazepines, across the Republic of Ireland for persons between the ages of 13 and 24, and compared usage between 2000 and 2012. Eighteen articles were included in the review. It was seen that tobacco, alcohol, and cannabis use has fallen in the lifetime and previous month use. The level of benzodiazepine use has remained similar in the period of study. Future work should redress the imbalance in substance use research that sees the majority of researchers looking at a few substances while little work is done on the others. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2392 / 2401
页数:10
相关论文
共 54 条
  • [1] [Anonymous], TEENAGE SMOKING ALCO
  • [2] [Anonymous], 2010, GLOB STRAT RED HARMF
  • [3] [Anonymous], DRUG REL DEATHS DRUG
  • [4] [Anonymous], STAT B 2011 DRUG REL
  • [5] [Anonymous], 2008, WHO report on the global tobacco epidemic, 2008: The MPOWER package
  • [6] [Anonymous], BENZ GOOD PRACT GUID
  • [7] [Anonymous], 2009, Global health risks: mortality and burden of disease attributable to selected major risks
  • [8] [Anonymous], HOM MESH NCBI
  • [9] [Anonymous], 1991, GOV STRAT PREV DRUG
  • [10] [Anonymous], DAT NAT DRUG REL DEA